Company / Operating Income
Nuvation Bio Inc. Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$213.1M
FY2025
5-year range
-$592.6M / -$93.3M
FY2021-FY2025
Trend
+64.0%
vs FY2024
Sector context
#147 of 204
Health Care
What the data says
At -$213M, Nuvation Bio Inc.'s operating income ranks #147 of 204 in the Health Care sector. Operating Income has fluctuated over the past 6 years, ranging from -$593M in FY2024 to -$44M in FY2020.
Based on SEC 10-K filings.
-$213M in FY2025.
Declined from -$100M to -$213M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#147 of 204 in Health CareTop 72% of 204This company -$213.1M Sector average $107.7M
▼
-297.8% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 64.0% year-over-year.
- Ranks #147 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$213.1M | +64.0% |
| FY2024 | -$592.6M | -493.7% |
| FY2023 | -$99.8M | +16.6% |
| FY2022 | -$119.7M | -28.3% |
| FY2021 | -$93.3M | -114.3% |
| FY2020 | -$43.6M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026